These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 3582746)

  • 81. Large-scale production of murine monoclonal antibodies using hollow fiber bioreactors.
    Evans TL; Miller RA
    Biotechniques; 1988 Sep; 6(8):762-7. PubMed ID: 3273638
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Step-up/step-down perfusion approach for increased mAb 520C9 production by a hybridoma cell line.
    Sen S; Roychoudhury PK
    Biotechnol Lett; 2013 Feb; 35(2):153-63. PubMed ID: 23086570
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effect of alpha-ketoglutarate on monoclonal antibody production of hybridoma cell lines in serum-free and serum-containing medium.
    Nilsang S; Kumar A; Rakshit SK
    Appl Biochem Biotechnol; 2008 Dec; 151(2-3):489-501. PubMed ID: 18696264
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A basic study on the hybridoma cell culture of microencapsulation.
    Ning G; Qian J; Guo M
    Chin J Biotechnol; 1992; 8(2):131-7. PubMed ID: 1297442
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Applications of improved stoichiometric model in medium design and fed-batch cultivation of animal cells in bioreactor.
    Xie L; Wang DI
    Cytotechnology; 1994; 15(1-3):17-29. PubMed ID: 7765929
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
    Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
    Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparison of a quadroma and its parent hybridomas in fed batch culture.
    Salazar-Kish JM; Heath CA
    J Biotechnol; 1993 Sep; 30(3):351-65. PubMed ID: 7764111
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Manufacture of pharmaceutical proteins from hybridomas and other cell substrates.
    Tolbert WR; Rupp RG
    Dev Biol Stand; 1989; 70():49-56. PubMed ID: 2503410
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Shear sensitivity of hybridoma cells in batch, fed-batch, and continuous cultures.
    Petersen JF; McIntire LV; Papoutsakis ET
    Biotechnol Prog; 1990; 6(2):114-20. PubMed ID: 1366545
    [TBL] [Abstract][Full Text] [Related]  

  • 90. On-line control of an immobilized hybridoma culture with multi-channel flow injection analysis.
    van der Pol JJ; Joksch B; Gätgens J; Biselli M; de Gooijer CD; Tramper J; Wandrey C
    J Biotechnol; 1995 Dec; 43(3):229-42. PubMed ID: 8590649
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of glucose on the production of recombinant protein C in mammalian cell culture.
    Sugiura T
    Biotechnol Bioeng; 1992 Apr; 39(9):953-9. PubMed ID: 18601033
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The enhancement of specific antibody production rate in glucose- and glutamine-controlled fed-batch culture.
    Omasa T; Ishimoto M; Higashiyama K; Shioya S; Suga K
    Cytotechnology; 1992; 8(1):75-84. PubMed ID: 1368407
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inclined sedimentation for selective retention of viable hybridomas in a continuous suspension bioreactor.
    Batt BC; Davis RH; Kompala DS
    Biotechnol Prog; 1990; 6(6):458-64. PubMed ID: 1366836
    [TBL] [Abstract][Full Text] [Related]  

  • 94. HBs-MAb production in perfusion culture with selective ammonia removal system.
    Nayve FR; Misato T; Matsumura M; Kataoka H
    J Biotechnol; 1994 May; 34(3):217-25. PubMed ID: 7764955
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Automated dynamic fed-batch process and media optimization for high productivity cell culture process development.
    Lu F; Toh PC; Burnett I; Li F; Hudson T; Amanullah A; Li J
    Biotechnol Bioeng; 2013 Jan; 110(1):191-205. PubMed ID: 22767053
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cell cycle- and growth phase-dependent variations in size distribution, antibody productivity, and oxygen demand in hybridoma cultures.
    Ramirez OT; Mutharasan R
    Biotechnol Bioeng; 1990 Oct; 36(8):839-48. PubMed ID: 18597283
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Calcium alginate immobilized hybridomas grown using a fluidized-bed perfusion system with a protein-free medium.
    Shen B; Greenfield P; Reid S
    Cytotechnology; 1994; 14(2):109-17. PubMed ID: 7765238
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Metabolic characteristics of GS-nS0 myeloma cells producing anti-CD25 monoclonal antibody in serum-free culture].
    Zhao L; Fan L; Zhang X; Tan W
    Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1069-76. PubMed ID: 19835150
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Studies on monoclonal antibody production by a hybridoma cell line (C1E3) immobilised in a fixed bed, porosphere culture system.
    Racher AJ; Looby D; Griffiths JB
    J Biotechnol; 1990 Jul; 15(1-2):129-45. PubMed ID: 1366685
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Study of metabolism and growth limitation of human leukemia cell lines.
    Horáková K; Valentová N; Chorváth B; Perényi T; Forgács A
    Neoplasma; 1989; 36(3):287-95. PubMed ID: 2739807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.